Reimagining the future of Huntington’s disease

SOPHIA Huntington’s Disease Community Advocate

Home hero advocate sophia 2

Press Releases

Jun 19, 2026
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
Jun 17, 2026
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
May 5, 2026
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

See All